We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBAN icon
101
Huntington Bancshares
HBAN
$35.6B
$309K 0.35%
34,148
+30,139
+752% +$267K
SEIC icon
102
SEI Investments
SEIC
$12.6B
$309K 0.35%
5,613
-1,777
-24% -$92.9K
GDDY icon
103
GoDaddy
GDDY
$11.6B
$302K 0.35%
4,113
+2,915
+243% +$209K
RARE icon
104
Ultragenyx Pharmaceutical
RARE
$2.64B
$302K 0.35%
+3,864
New +$256K
AME icon
105
Ametek
AME
$58B
$299K 0.34%
+3,349
New +$281K
UMPQ
106
DELISTED
Umpqua Holdings Corp
UMPQ
$299K 0.34%
+28,095
New +$314K
SBUX icon
107
Starbucks
SBUX
$119B
$297K 0.34%
4,031
+3,757
+1,371% +$282K
MET icon
108
MetLife
MET
$61.7B
$296K 0.34%
8,098
+7,858
+3,274% +$274K
CERN
109
DELISTED
Cerner Corp
CERN
$296K 0.34%
4,319
+4,265
+7,898% +$293K
LNC icon
110
Lincoln National
LNC
$8.75B
$295K 0.34%
+8,032
New +$283K
ALXN
111
DELISTED
Alexion Pharmaceuticals
ALXN
$290K 0.33%
2,587
+2,250
+668% +$239K
UDR icon
112
UDR
UDR
$12.1B
$286K 0.33%
+7,640
New +$285K
BAX icon
113
Baxter International
BAX
$14.4B
$280K 0.32%
3,249
+1,896
+140% +$165K
JCI icon
114
Johnson Controls International
JCI
$91.3B
$279K 0.32%
8,162
+4,362
+115% +$134K
NYT icon
115
New York Times
NYT
$10.5B
$277K 0.32%
6,591
+5,541
+528% +$202K
SPLK
116
DELISTED
Splunk Inc
SPLK
$275K 0.32%
+1,385
New +$219K
HAS icon
117
Hasbro
HAS
$13.3B
$271K 0.31%
+3,617
New +$262K
ENOV icon
118
Enovis
ENOV
$1.4B
$269K 0.31%
5,592
+5,018
+874% +$222K
IART icon
119
Integra LifeSciences
IART
$1.33B
$267K 0.31%
5,689
+3,527
+163% +$173K
QLYS icon
120
Qualys
QLYS
$6.43B
$267K 0.31%
+2,570
New +$269K
ACGL icon
121
Arch Capital
ACGL
$33.5B
$266K 0.31%
+9,297
New +$257K
PM icon
122
Philip Morris
PM
$290B
$265K 0.3%
3,777
-551
-13% -$40.2K
VRTX icon
123
Vertex Pharmaceuticals
VRTX
$133B
$263K 0.3%
+906
New +$246K
PSA icon
124
Public Storage
PSA
$60.8B
$261K 0.3%
1,361
+830
+156% +$160K
HR icon
125
Healthcare Realty
HR
$6.73B
$251K 0.29%
9,474
-10,798
-53% -$277K
3 4
5
6 7

Similar funds

KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
ACA
Anchorage Capital Advisors New York $378M AUM 13.47% 1-Year Est. Return
AFCM
Alta Fox Capital Management Fort Worth, Texas $378M AUM 59.19% 1-Year Est. Return
DAL
Delta Air Lines Atlanta, Georgia $378M AUM 12.68% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
WAM
Wakefield Asset Management Englewood, Colorado $377M AUM 38.72% 1-Year Est. Return
FP
Fivespan Partners San Francisco, California $377M AUM

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.